fluorouracil has been researched along with Adenocarcinoma, Papillary in 26 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since the prognosis of recurrent ovarian cancer patients is still poor, we need to establish a useful treatment strategy to achieve their long-term survival." | 2.73 | Weekly paclitaxel/5-fluorouracil followed by platinum retreatment for patients with recurrent ovarian cancer: a single institution experience. ( Ebina, Y; Hosaka, M; Mitamura, T; Moriwaki, M; Ohba, Y; Sakuragi, N; Takeda, M; Todo, Y; Watari, H, 2008) |
| "The authors conclude that multiple synchronous neoplasms can be treated with individualized chemotherapeutic protocol with good efficacy and few adverse reactions." | 1.42 | [Individualized therapy of synchronous ovarian and colon cancers with lymph]. ( Bishr, AM; Deme, D; Nizar, J; Telekes, A, 2015) |
| "Fresh samples of gastric cancer obtained from operation room were prepared to single-cell suspension (3 x 10(5) to 5 x 10(5) cells ml(-1)) and were separately exposed to taxol (TAX), cisplatin (CDDP), 5-fluorouracil (5-Fu), adriamycin (ADM), mitomycin (MMC) for 48 hours." | 1.34 | [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA]. ( Cao, YC; Fu, ZJ; Geng, M; Tai, YH; Wang, XY; Yin, YC, 2007) |
| "We experienced a case of recurrent gastric cancer with a long-term survival." | 1.31 | [Dormant chemotherapy by low-dose FP and low-dose UFT-E in recurrent gastric cancer with long-term survival--a case report]. ( Koyama, S; Shimoda, S; Takeda, N; Tanaka, N; Tsukahara, A; Yajima, K, 2002) |
| "Mitomycin C 26 mg was given intravenously on the day of operation and 5-fluorouracil (5-FU) 150 mg/day orally since postoperative 14th day as adjuvant chemotherapy." | 1.29 | [A case of advanced gastric cancer with liver metastasis with no recurrence and long survival]. ( Kajiura, Y; Kondo, Y; Mitomi, T; Miyaji, M; Nakamura, K; Ogoshi, K; Tajima, T, 1996) |
| "A patient with ovarian cancer recurrent in the pelvis showed partial response to consecutive intraarterial (IA) cisplatin (CDDP) combined with continuous IA 5FU treatment and received third look operation in which the recurrent tumor could not be completely removed." | 1.28 | [Successful treatment of a patient with recurrent ovarian cancer by lentinan combined with intraarterial 5FU]. ( Chen, JT; Fujimoto, I; Hamada, T; Hasumi, K; Hirai, Y; Masubuchi, K; Nakayama, K; Shimizu, Y; Teshima, H; Yamauchi, K, 1989) |
| "For the response of advanced gastric cancer to chemotherapy in the National Cancer Center Hospital, the combined use of UFT and Mitomycin C gave the highest rate, 46%." | 1.27 | Radiation therapy for advanced gastric cancer. ( Akine, Y; Egawa, S; Hijikata, J; Kajiura, Y; Kitagawa, T; Ogino, T; Tsukiyama, I; Yamashita, K, 1988) |
| "At present hyperthermia shows great promise when combined with other modalities." | 1.27 | [Clinical application of local hyperthermia combined with antineoplastic agents]. ( Ishiwata, J; Iwamoto, S; Koike, M; Maeda, Y; Masuda, T; Sasaki, T; Takeshita, Y; Tanaka, Y, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (38.46) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 3 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, L | 1 |
| Li, PF | 1 |
| Geng, M | 2 |
| Cao, YC | 2 |
| Yin, YC | 2 |
| Deme, D | 1 |
| Bishr, AM | 1 |
| Nizar, J | 1 |
| Telekes, A | 1 |
| Watari, H | 1 |
| Hosaka, M | 1 |
| Mitamura, T | 1 |
| Moriwaki, M | 1 |
| Ohba, Y | 1 |
| Todo, Y | 1 |
| Takeda, M | 1 |
| Ebina, Y | 1 |
| Sakuragi, N | 1 |
| Yamaoka, K | 1 |
| Inatsugi, N | 1 |
| Yoshikawa, S | 1 |
| Masuda, T | 2 |
| Uchida, H | 1 |
| Kuge, H | 1 |
| Yokotani, T | 1 |
| Yamaguchi, T | 1 |
| Kawaguchi, C | 1 |
| Shimobayashi, T | 1 |
| Inagaki, M | 1 |
| Matsuoka, M | 1 |
| Tatsumi, K | 1 |
| Saraya, T | 1 |
| Otsuji, T | 1 |
| Yamochi, Y | 1 |
| Yamanishi, K | 1 |
| Enomoto, Y | 1 |
| Nonomura, A | 1 |
| Sho, M | 1 |
| Nakajima, Y | 1 |
| Matsuda, M | 1 |
| Amemiya, H | 1 |
| Kono, H | 1 |
| Suzuki, T | 1 |
| Chang, MS | 1 |
| Izawa, S | 1 |
| Furuya, S | 1 |
| Takano, A | 1 |
| Matsumoto, Y | 1 |
| Fujii, H | 1 |
| Fu, ZJ | 1 |
| Wang, XY | 1 |
| Tai, YH | 1 |
| Okada, K | 1 |
| Kitade, F | 1 |
| Kawashima, Y | 1 |
| Yamada, S | 1 |
| Sakuramoto, K | 1 |
| Okajima, K | 1 |
| Nomura, N | 1 |
| Yamada, A | 1 |
| Saitou, F | 1 |
| Tsuzawa, T | 1 |
| Yamashita, I | 1 |
| Sakakibara, T | 1 |
| Shimizu, T | 1 |
| Sakamoto, T | 1 |
| Karaki, Y | 1 |
| Tazawa, K | 1 |
| Fujita, F | 1 |
| Fujita, M | 1 |
| Sakamoto, Y | 1 |
| Taguchi, T | 1 |
| Miyaji, M | 1 |
| Ogoshi, K | 1 |
| Kajiura, Y | 2 |
| Nakamura, K | 1 |
| Kondo, Y | 1 |
| Tajima, T | 1 |
| Mitomi, T | 1 |
| Lohwasser, S | 1 |
| Ernst, H | 1 |
| Hahn, EG | 1 |
| Gossner, L | 1 |
| Ell, C | 1 |
| Iwamoto, S | 2 |
| Kimoto, M | 1 |
| Mure, T | 1 |
| Imai, H | 1 |
| Fujimori, Y | 1 |
| Onuma, E | 1 |
| Iki, K | 1 |
| Yoshida, K | 1 |
| Tadaoka, Y | 1 |
| Kubozoe, T | 1 |
| Takeo, T | 1 |
| Murakami, T | 1 |
| Kawasaki, S | 1 |
| Yamamoto, Y | 1 |
| Tsunoda, T | 1 |
| Muguruma, K | 1 |
| Nakata, B | 1 |
| Hirakawa, K | 1 |
| Yamashita, Y | 1 |
| Onoda, N | 1 |
| Inoue, T | 1 |
| Matsuoka, T | 1 |
| Kato, Y | 1 |
| Sowa, M | 1 |
| Miya, K | 1 |
| Adachi, T | 1 |
| Nagao, N | 1 |
| Takagi, Y | 1 |
| Kawaguchi, Y | 1 |
| Kato, M | 1 |
| Takao, H | 1 |
| Sugiyama, Y | 1 |
| Kunieda, K | 1 |
| Umemoto, T | 1 |
| Fukada, D | 1 |
| Saji, S | 1 |
| Tanaka, N | 1 |
| Shimoda, S | 1 |
| Takeda, N | 1 |
| Koyama, S | 1 |
| Tsukahara, A | 1 |
| Yajima, K | 1 |
| Koyasaki, N | 1 |
| Matsumura, A | 1 |
| Kamata, T | 1 |
| Kanno, M | 1 |
| Rózewicki, S | 1 |
| Rzepka, I | 1 |
| Górski, H | 1 |
| Niimoto, M | 1 |
| Yamagata, S | 1 |
| Toge, T | 1 |
| Harada, T | 1 |
| Ikeda, H | 1 |
| Hattori, T | 1 |
| Iwase, K | 1 |
| Takenaka, H | 1 |
| Sumimura, J | 1 |
| Ishizaka, T | 1 |
| Takagaki, M | 1 |
| Bessho, T | 1 |
| Ohata, T | 1 |
| Inoue, M | 1 |
| Oshima, S | 1 |
| Tanaka, T | 1 |
| Kono, A | 1 |
| Hara, Y | 1 |
| Furusawa, M | 1 |
| Shimizu, Y | 1 |
| Hasumi, K | 1 |
| Chen, JT | 1 |
| Hirai, Y | 1 |
| Nakayama, K | 1 |
| Teshima, H | 1 |
| Hamada, T | 1 |
| Fujimoto, I | 1 |
| Yamauchi, K | 1 |
| Masubuchi, K | 1 |
| Tsukiyama, I | 1 |
| Akine, Y | 1 |
| Ogino, T | 1 |
| Yamashita, K | 1 |
| Egawa, S | 1 |
| Hijikata, J | 1 |
| Kitagawa, T | 1 |
| Maehara, Y | 1 |
| Anai, H | 1 |
| Kusumoto, H | 1 |
| Sugimachi, K | 1 |
| Neumann, R | 1 |
| Common, H | 1 |
| Ricken, D | 1 |
| Ishiwata, J | 1 |
| Sasaki, T | 1 |
| Koike, M | 1 |
| Maeda, Y | 1 |
| Takeshita, Y | 1 |
| Tanaka, Y | 1 |
| Shaw, BW | 1 |
| Roszmann, MH | 1 |
1 review available for fluorouracil and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
[A surgical (pancreatoduodenectomy) case of lymph node metastatic recurrence of colon cancer after chemotherapy].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Duoden | 2010 |
2 trials available for fluorouracil and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Weekly paclitaxel/5-fluorouracil followed by platinum retreatment for patients with recurrent ovarian cancer: a single institution experience.
Topics: Adenocarcinoma, Papillary; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phyt | 2008 |
[Clinical evaluation of intermittent hepatic arterial infusion therapy for metastatic liver tumor of gastric and colorectal cancer].
Topics: Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; C | 1998 |
23 other studies available for fluorouracil and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Agents; Biomarke | 2013 |
[Individualized therapy of synchronous ovarian and colon cancers with lymph].
Topics: Abdominal Pain; Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; | 2015 |
A huge primary peritoneal papillary adenocarcinoma which demonstrated imaging findings similar to those of extrahepatic-growing type hepatic tumor: report of a case.
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Agents; Cisplatin; Diagnosis, Differential; Female; | 2005 |
[Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antineoplastic; Antim | 2007 |
Clinical evaluation of preoperative combined chemotherapy with neocarzinostatin (NCS) and 5-Fluorouracil (combined NF therapy) against gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Antibiotics, Antin | 1981 |
[Successful treatment of advanced gastric cancer (Borrmann 1 type) with FTP chemotherapy after reduction surgery].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; C | 1994 |
[Antitumor activity of combination treatment of BOF-A2 with CDDP against human lung cancers xenografted in nude mice].
Topics: Adenocarcinoma, Papillary; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Car | 1993 |
[A case of advanced gastric cancer with liver metastasis with no recurrence and long survival].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; C | 1996 |
[Morphological changes in human colon carcinoma after chemotherapy with 5-fluorouracil--a study in the nude mouse model].
Topics: Adenocarcinoma, Papillary; Animals; Antimetabolites, Antineoplastic; Cell Survival; Colonic Neoplasm | 1997 |
[A case of papillary adenocarcinoma of the stomach with liver metastases and carcinomatous peritonitis treated effectively by methotrexate/5-fluorouracil sequential chemotherapy].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; D | 1997 |
[p53 and Bax protein expression as predictor of chemotherapeutic effect in gastric carcinoma].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Apo | 1998 |
[Dormant chemotherapy by low-dose FP and low-dose UFT-E in recurrent gastric cancer with long-term survival--a case report].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administr | 2002 |
[A case of advanced gastric carcinoma with liver metastasis with no recurrence and long survival by means of surgery and postoperative chemotherapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2002 |
[Early results of polychemotherapy in advanced ovarian tumors].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Aged; Carcinoma, Papillary; Cyclophosphamide; Cyst | 1979 |
Evaluation of chemotherapeutic effects on gastric cancer in relation to the histological pattern.
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Cytarabine; Drug Therapy, Combination; Fluorouracil; Huma | 1978 |
[A five-year-survival case in which complete response was recognized after combined chemotherapy using 5-fluorouracil, adriamycin and mitomycin C (FAM) for unresectable gastric cancer].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Fluoro | 1992 |
[Effect of uracil on the both reactions, 5-fluorouracil degradation into 2-fluoro-beta-alanine and 5-fluorouracil splitting from tegafur in human tumor].
Topics: Adenocarcinoma, Papillary; Alanine; beta-Alanine; Fluorouracil; Humans; Lung Neoplasms; Tegafur; Tum | 1989 |
[Successful treatment of a patient with recurrent ovarian cancer by lentinan combined with intraarterial 5FU].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hum | 1989 |
Radiation therapy for advanced gastric cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Adult; Aged; Aged, 80 and over; | 1988 |
Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma.
Topics: Aclarubicin; Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Antineoplastic Age | 1987 |
[Metastasizing primary duodenal cancer. Extended remission in a patient following chemotherapy].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality T | 1986 |
[Clinical application of local hyperthermia combined with antineoplastic agents].
Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Adult; Aged; Antineoplastic Agents; Body Temperature; Cis | 1985 |
Carcinoma of the common bile duct. Report of an unusual two-year remission after intraluminal 5-fluorouracil.
Topics: Adenocarcinoma, Papillary; Bile Duct Neoplasms; Cholangiography; Common Bile Duct; Female; Fluoroura | 1972 |